Reduce unnecessary hematology referrals for multiple myeloma patients
12 May 2024
Prof. Guy Pratt, Honorary Consultant Haematologist, Professor of Haematology (Haem-Oncology), Institute of Cancer and Genomic Sciences, University of Birmingham, discusses when and how urgently to refer myeloma patients, and highlights how both primary care practitioners and clinical laboratories can help guide blood test requesting and appropriate hematology referral.
About the company
Binding Site
Binding Site, part of Thermo Fisher Scientific, is committed to improving patient lives worldwide through education, collaboration and innovation
Binding Site provide diagnostic solutions that help doctors, clinicians and laboratory researchers across the globe diagnose and monitor blood cancers and immune system disorders.
Founded by researchers at the University of Birmingham, Binding Site has continued to build on its strong scientific foundations, supporting research and development within our field and responding to the changing needs of patients, researchers and clinicians for over 30 years.
We are committed to working in collaboration with our partners and customers to lead the way in specialised medical diagnostics, ensuring we continue to make a difference together.
